OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer

Published on February 14, 2025

oncology assets for patients. OnCusp raised an oversubscribed $100 million Series A financing round in January 2024,co-led by Novo Holdings,

Continue reading on website
Other news

'Woody,' 'spicy' and 'sweet': Smell of ancient Egyptian mummified bodies reveals new insights into embalming practices

February 14, 2025
ancient embalming materials. It adds another layer of data to enrich the museum exhibition of mummified bodies."Dr. Cecilia Bembibre (UCL

State Sen. Thompson dies after com­pli­ca­tions from knee surgery, family says

February 14, 2025
“Her tireless work in education, healthcare, and civil rights, including her leadership to establish the Wells’Built museum of African